Related Experiment Video
Updated: Jul 9, 2026

11:15
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
A three-stage experimental strategy to evaluate and validate an interplate IC50 format
Daniel J Rodrigues1, Richard Lyons, Philip Laflin
1High Throughput Screening Centre of Emphasis, Worldwide Research, Sandwich, UK. dan.rodrigues@pfizer.com
Assay and Drug Development Technologies
|December 7, 2007
Summary
Running 50% inhibitory concentration (IC50) experiments in an interplate format accelerates compound testing and increases potential doses. This strategy ensures data quality is equivalent to traditional methods, enhancing drug discovery throughput.
Area of Science:
- Biochemistry
- Pharmacology
- Drug Discovery
Background:
- Serial dilution for compound potency determination can be a bottleneck in research projects.
- Traditional methods for establishing 50% inhibitory concentration (IC50) can be time-consuming.
Purpose of the Study:
- To investigate the feasibility of an interplate format for IC50 experiments.
- To develop and validate a strategy for assessing interplate assay data quality compared to intraplate formats.
- To enhance the throughput and efficiency of compound testing in drug discovery.
Main Methods:
- A three-stage approach was adopted to assess and validate the interplate format against the intraplate format.
- Dose ranges were constructed across plates to facilitate interplate IC50 experiments.
- The strategy was tested using two different assay formats.
Main Results:
- The interplate format demonstrated potential for faster reformatting and generation of more doses.
- This approach can lead to higher-throughput and more timely compound testing.
- The feasibility assessment strategy ensured data quality equivalent to historical formats.
Conclusions:
- An interplate format for IC50 determination is feasible and offers advantages in speed and throughput.
- The proposed three-stage strategy is effective for validating new assay formats.
- This methodology can be adapted to assess other assay types for improved drug discovery efficiency.

